
Eisai To Divest Rights For Pariet In China To Peak Pharma
(MENAFN- JCN NewsWire) Eisai to Divest Rights for Pariet in China to Peak Pharma TOKYO, Apr 1, 2025 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest the rights for proton pump inhibitor Pariet® (generic …